POM-V Prescription Required Companion Animal

Meloxoral 0.5 mg/ml Oral Suspension for Cats

Active ingredient: Meloxicam

Form

Liquid

Species

Cats

Manufacturer

Dechra Regulatory B.V.

VMD MA No.

50406/5000

What it's used for

Alleviation of pain and inflammation in chronic musculo-skeletal disorders in cats.

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Meloxicam

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Meloxoral 0.5 mg/ml Oral Suspension for Cats — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 26 Mar 2026.

Alleviation of pain and inflammation in chronic musculo-skeletal disorders in
cats.

Do not use in cats suffering from gastrointestinal disorders such as irritation
and haemorrhage, impaired hepatic, cardiac or renal function and
haemorrhagic disorders.
Do not use in case of hypersensitivity to the active substance or to any of the
excipients.
Do not use in cats less than 6 weeks of age.
See section 4.7.

Cats:
Very Rare
(<1 animal / 10,000
treated, including
isolated reports):
Appetite loss
, Apathy
Vomiting
, Diarrhoea
,
Renal failure
Elevated liver enzymes
Undetermined
frequency (cannot
be estimated from
the available data)
Blood in faeces
1, 2
These adverse reactions are in most cases transient and disappear following
termination of the treatment but in very rare cases may be serious or fatal. If
adverse reactions occur, treatment should be discontinued and the advice of a
veterinarian should be sought.
occult
Reporting adverse events is important. It allows continuous safety monitoring of
a veterinary medicinal product. Reports should be sent, preferably via a
veterinarian, to either the marketing authorisation holder or its local
representative or the national competent authority via the national reporting
system. See the package leaflet for respective contact details.

None.

Issued May 2024
AN: 01166/2023

Special precautions for use in animals
Avoid use in any dehydrated, hypovolaemic or hypotensive animal, as there is
a potential risk of renal toxicity.
Response to long-term therapy should be monitored at regular intervals by a
veterinary surgeon.
Special precautions to be taken by the person administering the veterinary
medicinal product to animals
People with known hypersensitivity to NSAIDs should avoid contact with the
veterinary medicinal product.
In case of accidental ingestion, seek medical advice immediately and show the
package leaflet or the label to the physician.
Special precautions for the protection of the environment:
Not applicable.
Other precautions:
Not applicable.

Other NSAIDs, diuretics, anticoagulants, aminoglycoside antibiotics and
substances with high protein binding may compete for binding and thus lead to
toxic effects. Meloxoral must not be administered in conjunction with other
NSAIDs or glucocorticosteroids. Concurrent administration of potential
nephrotoxic veterinary medicinal products should be avoided.
Pre-treatment with anti-inflammatory substances may result in additional or
increased adverse effects and accordingly a treatment-free period with such
veterinary medicinal products should be observed for at least 24 hours before
commencement of treatment. The treatment-free period, however, should take
into account the pharmacokinetic properties of the products used previously.

This veterinary medicinal product does not require any special storage
conditions.

Not applicable.
5.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.